Xencor Inc
F:XE9
Xencor Inc
F:XE9
Price:
10.1
EUR
5.76%
Market Cap:
€622.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
X
|
Xencor Inc
F:XE9
|
US |
|
C
|
Cummins Inc
LSE:0I58
|
US |
|
Velocity Composites PLC
LSE:VEL
|
UK |
|
T
|
Toyo Tanso Co Ltd
TSE:5310
|
JP |
|
M
|
Moonbae Steel Co Ltd
KRX:008420
|
KR |
|
Camlin Fine Sciences Ltd
NSE:CAMLINFINE
|
IN |
|
JD Health International Inc
HKEX:6618
|
CN |
|
I
|
Intel Corp
SGO:INTC
|
US |
|
Golden Minerals Co
TSX:AUMN
|
US |
|
Sabina Gold & Silver Corp
TSX:SBB
|
CA |
|
Y
|
Yuken India Ltd
NSE:YUKEN
|
IN |
|
C
|
Coca-Cola Co
BMV:KO
|
US |
|
Blaize Holdings Inc
NASDAQ:BZAI
|
US |
Multiples-Based Value
The
Multiples-Based Value for
Xencor Inc (XE9)
under the Base Case is
hidden
EUR.
Compared with the current market price of 10.1 EUR, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
XE9 Multiples-Based Value
LOCKED
Multiples Across Competitors
XE9 Competitors Multiples
Xencor Inc Competitors
Xencor Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Xencor Inc
F:XE9
|
900.6m EUR | 7.2 | -9.8 | -2.6 | -2.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.1B USD | 6.2 | 90.8 | 15 | 20.8 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
362.4B USD | 111.6 | -1 741.9 | 951.3 | -107.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD | 5.2 | 24.7 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.1B USD | 5.9 | 20.5 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.6B USD | 9.5 | 28.7 | 21.6 | 22.6 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.2B USD | 5.7 | 18.2 | 13.7 | 15.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD | 3.1 | 34 | 11.3 | 14.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
